Heilongjiang ZBD Pharmaceutical Co Ltd Asset Resilience Ratio

Latest as of March 2026: 0.00%

Heilongjiang ZBD Pharmaceutical Co Ltd asset resilience ratio. Heilongjiang ZBD Pharmaceutical Co Ltd (603567) has an Asset Resilience Ratio of 0.00% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Heilongjiang ZBD Pharmaceutical Co Ltd liquidity coverage in days to measure how many days the company can operate on defensive assets alone.

Liquid Assets

CN¥406.37K
≈ $59.46K USD Cash + Short-term Investments

Total Assets

CN¥10.50 Billion
≈ $1.54 Billion USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio of Heilongjiang ZBD Pharmaceutical Co Ltd (2016–2025)

Asset resilience ratio of Heilongjiang ZBD Pharmaceutical Co Ltd from 2016 to 2025. This chart shows how Heilongjiang ZBD Pharmaceutical Co Ltd's Asset Resilience Ratio has changed over time. Read total liabilities of Heilongjiang ZBD Pharmaceutical Co Ltd for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Heilongjiang ZBD Pharmaceutical Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Heilongjiang ZBD Pharmaceutical Co Ltd asset portfolio.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents CN¥0.00 0%
Short-term Investments CN¥406.37K 0.0%
Total Liquid Assets CN¥406.37K 0.00%

Asset Resilience Insights

  • Limited Liquidity: Heilongjiang ZBD Pharmaceutical Co Ltd maintains only 0.00% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Heilongjiang ZBD Pharmaceutical Co Ltd Industry Peers by Asset Resilience Ratio

Compare Heilongjiang ZBD Pharmaceutical Co Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Takeda Pharmaceutical Company Limited
F:TKDA
Drug Manufacturers - Specialty & Generic 0.69%
Takeda Pharmaceutical Co Ltd ADR
NYSE:TAK
Drug Manufacturers - Specialty & Generic 4.94%
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
F:RIG2
Drug Manufacturers - Specialty & Generic 0.20%
Ajanta Pharma Limited
NSE:AJANTPHARM
Drug Manufacturers - Specialty & Generic 14.99%
Changchun High & New Technology Industries Group Inc
SHE:000661
Drug Manufacturers - Specialty & Generic 5.50%
Jiangsu Nhwa Pharmaceutical Co Ltd
SHE:002262
Drug Manufacturers - Specialty & Generic 26.45%
Porton Fine Chemicals Ltd
SHE:300363
Drug Manufacturers - Specialty & Generic 6.85%
Jubilant Pharmova Limited
NSE:JUBLPHARMA
Drug Manufacturers - Specialty & Generic 1.26%

Heilongjiang ZBD Pharmaceutical Co Ltd Asset Resilience Ratio by Year (2016–2025)

Heilongjiang ZBD Pharmaceutical Co Ltd asset resilience ratio by year from 2016 to 2025. The table below shows the annual Asset Resilience Ratio data for Heilongjiang ZBD Pharmaceutical Co Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-12-31 0.00% CN¥438.51K
≈ $64.17K
CN¥10.63 Billion
≈ $1.56 Billion
0.00pp
2024-12-31 0.00% CN¥537.23K
≈ $78.61K
CN¥12.71 Billion
≈ $1.86 Billion
+0.00pp
2023-12-31 0.00% CN¥427.03K
≈ $62.49K
CN¥12.47 Billion
≈ $1.82 Billion
0.00pp
2022-12-31 0.00% CN¥505.09K
≈ $73.91K
CN¥11.68 Billion
≈ $1.71 Billion
-6.16pp
2016-12-31 6.17% CN¥396.00 Million
≈ $57.95 Million
CN¥6.42 Billion
≈ $939.30 Million
--
pp = percentage points

About Heilongjiang ZBD Pharmaceutical Co Ltd

SHG:603567 China Drug Manufacturers - Specialty & Generic
Market Cap
$689.31 Million
CN¥4.71 Billion CNY
Market Cap Rank
#10294 Global
#2721 in China
Share Price
CN¥5.01
Change (1 day)
-1.38%
52-Week Range
CN¥4.28 - CN¥11.70
All Time High
CN¥28.17
About

Heilongjiang ZBD Pharmaceutical Co., Ltd. engages in the pharmaceuticals business in China. The company researches, develops, produces, and sale traditional Chinese medicine preparations, biological agents, and chemical agents, as well as involved in the pharmaceutical and Chinese medicinal materials trade; and leasing business. It also engages in pharmaceutical manufacturing; contract manufactur… Read more